“Clinical Implications, Safety, Efficacy of Recombinant Human Granulocyte Colony-Stimulating Factors and Pegylated Equivalent”. 2022. Epidemiology, Biostatistics, and Public Health 10 (4). https://doi.org/10.2427/8845.